Personal profile
Specialisation
Immunotherapy, cancer, inflammatory diseases, antibodies, immunology
Research interests
Since the start of her career Prof. dr. van Egmond has studied the function of antibodies, with emphasis on understanding the role of immunoglobulin A (IgA) in physiology and pathology. Her research also addresses (1) the contribution of abnormal antibody responses in chronic inflammation and autoimmunity and (2) monoclonal antibody therapy of cancer. Prof. dr. van Egmond’s research is highly translational and she has a cross appointment with the Department of Surgery and the Department of Molecular Cell Biology and Immunology at Amsterdam UMC, to facilitate the rapid progression of pre-clinical findings into clinical applications. Prof.dr. van Egmond is the spokeswoman of the Dutch Society for Immunology, and since the COVID-19 crisis she has an active role in providing information on the immune system and vaccines to the general public.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
An act of revision: IgA in health and disease
van Gool, M. M. J., 26 Jan 2023, s.l.: Ridderprint. 225 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
Surgery for colorectal cancer: a trigger for liver metastases development? New insights into the underlying mechanisms
Grewal, S. K., 27 Oct 2022, 218 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
Open Access -
Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer
Sewnath, C., Behrens, L. & van Egmond, M., 19 Jul 2022, In: Expert opinion on biological therapy. 22, 8, p. 983–995 13 p.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile12 Downloads (Pure) -
Anti-SARS-CoV-2 Spike IgA2 Induces Inflammation by Human Macrophages
Mes, L., Veth, J., Van Coillie, J., Keijser, J. B. D., Mantel, E., van der Mast, R., Rispens, T., Vidarsson, G., van Egmond, M., den Dunnen, J. & Chen, H. J., Oct 2025, In: European journal of immunology. 55, 10, e70068.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile10 Downloads (Pure) -
Enhancing activity of FcαRI-bispecific antibodies using glycoengineering
Sewnath, C. L. A. N., Damelang, T., Bentlage, A. E. H., Kroode, L. T., Tuk, C. W., Visser, R., Wuhrer, M., van Coillie, J., Rispens, T., van Egmond, M. & Vidarsson, G., 1 Jun 2025, In: Journal of Immunology. 214, 6, p. 1261-1271 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile11 Downloads (Pure)
-
Dutch Cancer Foundation (External organisation)
van Egmond, M. (Member)
1 Jan 2024 → …Activity: Membership › Membership of board › Academic
-
Neutrophils and cancer immunotherapy
van Egmond, M. (Speaker)
22 Nov 2023Activity: Talk or presentation › Invited talk › Academic
-
Novel FcαRI Bispecific Antibody Immunocytokines for the Recruitment of Myeloid Effector Cells in Cancer Therapy
van Egmond, M. (Speaker)
14 Nov 2023Activity: Talk or presentation › Invited talk › Academic
-
Novel Bispecific Antibody Immunocytokines for the Recruitment of Myeloid Effector Cells in Cancer Therapy
van Egmond, M. (Speaker)
21 Jun 2023Activity: Talk or presentation › Invited talk › Academic
-
Academic founder and consultant
van Egmond, M. (Consultant)
1 Jun 2023 → …Activity: Consultancy › Academic
Prizes
Press/Media
-
TV interview Tijd voor Max over immuuntherapie van kanker
02/11/2023
1 Media contribution
Press/Media: Press / Media
-
Interview tijdschrift ‘Kijk over immuuntherapie van kanker
01/11/2023
1 Media contribution
Press/Media: Press / Media
-
-
-